Cargando…

Role of Comorbidities in Optimizing Decision-Making for Allogeneic Hematopoietic Cell Transplantation

Allogeneic conventional hematopoietic cell transplantation (HCT) following high-dose, myeloablative conditioning regimens has been used since the 1970’s as potentially curative treatment for patients with malignant, hematological disorders. The toxicities of conditioning regimens have limited conven...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sorror, Mohamed L., Storb, Rainer F.
Formato:	Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2010
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997746/ https://www.ncbi.nlm.nih.gov/pubmed/21152378 http://dx.doi.org/10.4084/MJHID.2010.015

Ejemplares similares

What Role Is There for Antithymocyte Globulin in Allogeneic Nonmyeloablative Canine Hematopoietic Cell Transplantation?
por: Diaconescu, Razvan, et al.
Publicado: (2005)

Comparison of Minimal Residual Disease as Outcome Predictor for AML Patients in First Complete Remission Undergoing Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation
por: Walter, Roland B., et al.
Publicado: (2014)

Pre-transplant expressions of microRNAs, comorbidities, and post-transplant mortality
por: Sorror, Mohamed L., et al.
Publicado: (2018)

History of hematopoietic cell transplantation: challenges and progress
por: Granot, Noa, et al.
Publicado: (2020)

Optimizing allogeneic grafts in hematopoietic stem cell transplantation
por: Xu, Zheng‐Li, et al.
Publicado: (2021)

Impact of Pre-Transplant Measurable Residual Disease on Outcome of Allogeneic Hematopoietic Cell Transplantation in Adult Monosomal Karyotype AML
por: Morsink, Linde M., et al.
Publicado: (2020)

Cardiopulmonary Exercise Test With Comorbidity Index Before Allogeneic Hematopoietic Stem Cell Transplantation
por: Yeon, Sang Hoon, et al.
Publicado: (2022)

Prognostic factors and outcomes of severe gastrointestinal graft-vs.-host disease after allogeneic hematopoietic cell transplantation
por: Castilla-Llorente, Cristina, et al.
Publicado: (2014)

Hematopoietic Cell Transplantation Provides an Immune-tolerant Platform for Myoblast Transplantation in Dystrophic Dogs
por: Parker, Maura H, et al.
Publicado: (2008)

Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma
por: Maffini, Enrico, et al.
Publicado: (2019)

Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: improved outcomes over two decades
por: Cooper, Jason P., et al.
Publicado: (2020)

The Role of Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Leukemia
por: Algeri, Mattia, et al.
Publicado: (2021)

cGMP production of astatine-211-labeled anti-CD45 antibodies for use in allogeneic hematopoietic cell transplantation for treatment of advanced hematopoietic malignancies
por: Li, Yawen, et al.
Publicado: (2018)

Rituximab-based allogeneic transplant for chronic lymphocytic leukemia with comparison to historical experience
por: Shadman, Mazyar, et al.
Publicado: (2019)

Extracorporeal Photopheresis in Addition to Pentostatin in Conditioning for Canine Hematopoietic Cell Transplantation: Role in Engraftment
por: Bethge, Wolfgang A., et al.
Publicado: (2010)

Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome
por: Alessandrino, Emilio Paolo, et al.
Publicado: (2013)

The Quality of Life of Adult Survivors of Childhood Hematopoietic Cell Transplant
por: Sanders, Jean E., et al.
Publicado: (2009)

Association of pre-existing comorbidities with outcome of allogeneic hematopoietic cell transplantation. A retrospective analysis from the EBMT
por: Penack, Olaf, et al.
Publicado: (2021)

Utility of Treatment-Related Mortality (TRM) Score to Predict Outcomes of Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
por: Zarling, Lucas C., et al.
Publicado: (2022)

Cytotoxic Pathways in Allogeneic Hematopoietic Cell Transplantation
por: Du, Wei, et al.
Publicado: (2018)

Allogeneic hematopoietic stem-cell transplantation for myelofibrosis
por: Zhang, Lining, et al.
Publicado: (2020)

Allogeneic Hematopoietic Cell Transplantation and Cellular Therapy
por: Kim, Hee-Je, et al.
Publicado: (2021)

Adoptive Immunotherapy Against Allogeneic Kidney Grafts in Dogs with Stable Hematopoietic Trichimerism
por: Graves, Scott S., et al.
Publicado: (2008)

The emerging roles of the gut microbiome in allogeneic hematopoietic stem cell transplantation
por: Khuat, Lam T., et al.
Publicado: (2021)

Assessing the Influence of Different Comorbidities Indexes on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in a Developing Country
por: Teixeira, Gustavo Machado, et al.
Publicado: (2015)

Conditioning Intensity, Pre-Transplant Flow Cytometric Measurable Residual Disease, and Outcome in Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
por: Morsink, Linde M., et al.
Publicado: (2020)

Optimal Treatment Duration of Pseudomonas aeruginosa Infections in Allogeneic Hematopoietic Cell Transplant Recipients
por: Olearo, Flaminia, et al.
Publicado: (2020)

Population Pharmacokinetics of Caspofungin and Dosing Optimization in Children With Allogeneic Hematopoietic Stem Cell Transplantation
por: Niu, Chang-He, et al.
Publicado: (2020)

Contribution of measurable residual disease status to prediction accuracy of relapse and survival in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation
por: Rodríguez-Arbolí, Eduardo, et al.
Publicado: (2022)

Allogeneic hematopoietic stem cell transplantation for non-malignant hematological disorders
por: Mahmoud, Hossam K., et al.
Publicado: (2015)

Hemorrhagic cystitis following allogeneic hematopoietic cell transplantation.
por: Lee, Gyeong-Won, et al.
Publicado: (2003)

Allogeneic hematopoietic stem cell transplantation in mycosis fungoides
por: Atalla, Angelo, et al.
Publicado: (2013)

Ectonucleotidases in Solid Organ and Allogeneic Hematopoietic Cell Transplantation
por: Chernogorova, Petya, et al.
Publicado: (2012)

Epigenetic therapy in allogeneic hematopoietic stem cell transplantation
por: Bashir, Qaiser, et al.
Publicado: (2013)

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR NEUROBLASTOMA: THE CIBMTR EXPERIENCE
por: Hale, Gregory A., et al.
Publicado: (2013)

Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation
por: Raghunathan, Vikram M., et al.
Publicado: (2016)

Autoimmunity Following Allogeneic Hematopoietic Stem Cell Transplantation
por: Buxbaum, Nataliya Prokopenko, et al.
Publicado: (2020)

The role of allogeneic hematopoietic stem cell transplantation in the four P medicine era
por: Morello, Enrico, et al.
Publicado: (2018)

The Role of Immune Checkpoint Molecules for Relapse After Allogeneic Hematopoietic Cell Transplantation
por: Köhler, Natalie, et al.
Publicado: (2021)

Uncovering the multifaceted roles played by neutrophils in allogeneic hematopoietic stem cell transplantation
por: Tecchio, Cristina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7h1gs6rq0cd8jd6t6m08i1or36